New Animal Health Products, Vaccine Sales Support PAHC Stock

Phibro Animal Health's (PAHC) diversified product portfolio and wide presence in key growth areas bolster our confidence in the stock. The stock carries a Zacks Rank #2 (Buy). Factors to Drive PAHC's Growth Phibro's existing operations and established sales, marketing and distribution network in over 80 countries provide ample scope to take advantage of global growth opportunities. Outside the United States, Phibro's global footprint extends to key high-growth regions (countries where the livestock producti ...